Microbiotica
1 known investors
Microbiotica develops defined live biotherapeutic products based on microbiome science for immuno-oncology and inflammatory bowel disease treatment. The company uses a clinic-led discovery platform to identify specific bacteria linked to patient outcomes and target patient populations.
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- MICROBIOTICA LIMITED
- Company number
- 10269808
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 8 Jul 2016
- Registered office
- Chesterford Research Park, Little Chesterford, Cambridge, CB10 1XL
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 7 Jul 2026 · next due 21 Jul 2027
Current officers · 7
- Carmine Daniel Circelli — director, appointed 12 Jan 2023
- Viet-Anh Anne Horgan — director, appointed 1 May 2025
- Trevor David Lawley — director, appointed 8 Jul 2016
- Mark Royston Quick — director, appointed 4 Mar 2022
- Johannes Gerardus Christiaan Petrus Schikan — director, appointed 1 Feb 2021
- Timothy Sharpington — director, appointed 1 Jan 2023
- Ip2ipo Services Limited — corporate director, appointed 15 Dec 2016
Source: Companies House public register · retrieved 7 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.